“State-level caps on insulin out-of-pocket costs do not meaningfully increase insulin utilization,” Kelly E. Anderson, PhD, told Healio. “Our research shows this is likely due in part to many commercial enrollees paying out-of-pocket amounts below the cap levels even prior to cap implementation.”